
Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
Read MoreLatest Financial News in The Ivy
Market Commentary: Time To Buy This 9.12% Yield Stock?
It’s rare to find a stock offering a 9%+ yield that doesn’t have some murkiness under the hood, but is Medical Properties Trust (NYSE: MPW) that diamond in the rough?
We investigate whether this REIT that specializes in leasing healthcare facilities, a segment that has been traditionally regarded as recession-resistant, is worthy of a portfolio spot now.
» Read more about: Market Commentary: Time To Buy This 9.12% Yield Stock? »
Read MoreMarket Commentary: Why Tesla Could 4x in the Next 7 Years
The founder of Baron Capital, a firm with approximately $50 billion under management, believes that Tesla has the potential to quadruple in value over the next seven years.
Ron Baron isn’t just a voice in the wind, his fund has delivered an annualized return of 15.4% over the last 20 years, handily beating the S&P 500.
» Read more about: Market Commentary: Why Tesla Could 4x in the Next 7 Years »
Read MoreMarket Commentary: 1 Monthly Income Play You Don’t Want To Miss
If getting paid passively monthly sounds like something you’ve been looking for, Realty Income might be just the stock you’ve been looking for. From a single store 54 years ago, Realty Income is now a true behemoth that rewards investors seeking monthly income.
Read MoreAlert: 1 Fast Growth Stock To Buy On The Dip
Investment Alert: Buy Teladoc (TDOC) Under $23/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Read MoreLatest Financial News in The Spotlight

Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
The Burst
Market Commentary: Why Tesla Could 4x in the Next 7 Years
The founder of Baron Capital, a firm with approximately $50 billion under management, believes that Tesla has the potential to quadruple in value over the next seven years.
Ron Baron isn’t just a voice in the wind, his fund has delivered an annualized return of 15.4% over the last 20 years, handily beating the S&P 500.
» Read more about: Market Commentary: Why Tesla Could 4x in the Next 7 Years »
Read MoreMarket Commentary: 1 Growth Stock That Is Crushing Asia
Crocs (NASDAQ:CROX) has been a roller-coaster of an investment, to say the least. From lows of $10 in 2020 to highs around $180 in 2021 and back under $50 again in 2022, the share price has bucked investors around like a wild bull at a county fair.
And despite falling far short of the market this year –
» Read more about: Market Commentary: 1 Growth Stock That Is Crushing Asia »
Market Commentary: 1 Warren Buffett Stock to Go Nuts Over
When it comes to rewarding shareholders, Warren Buffett is a maestro. His behemoth of an investment firm, Berkshire Hathaway, manages over $380 billion in investments, mostly in companies with burgeoning dividends.
Alert: 61.9% Upside Ahead of Flu Season
Investment Alert: Buy Moderna (MRNA) Under $115/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
The global landscape shaped by the COVID-19 pandemic is gradually evolving.
» Read more about: Alert: 61.9% Upside Ahead of Flu Season »
The Ivy
Market Commentary: Time To Buy This 9.12% Yield Stock?
It’s rare to find a stock offering a 9%+ yield that doesn’t have some murkiness under the hood, but is Medical Properties Trust (NYSE: MPW) that diamond in the rough?
We investigate whether this REIT that specializes in leasing healthcare facilities, a segment that has been traditionally regarded as recession-resistant, is worthy of a portfolio spot now.
» Read more about: Market Commentary: Time To Buy This 9.12% Yield Stock? »
Read MoreMarket Commentary: 1 Monthly Income Play You Don’t Want To Miss
If getting paid passively monthly sounds like something you’ve been looking for, Realty Income might be just the stock you’ve been looking for. From a single store 54 years ago, Realty Income is now a true behemoth that rewards investors seeking monthly income.
Alert: 1 Warren Buffett Stock To Buy Before Takeoff
Investment Alert: Buy Coca Cola (KO) Under $59/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
A glance at Berkshire’s portfolio will reveal Coca-Cola as one of its heavyweight investments,
» Read more about: Alert: 1 Warren Buffett Stock To Buy Before Takeoff »
Alert: 1 Fast Growth Stock To Buy On The Dip
Investment Alert: Buy Teladoc (TDOC) Under $23/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
The Daily
Anndy Lian: The Complex Challenges Faced by Cryptocurrency Exchanges
Cryptocurrency exchanges play a pivotal role as the gatekeepers of the digital asset realm. These platforms provide users with the means to trade, buy, and sell cryptocurrencies, serving as crucial hubs of liquidity and accessibility for a global audience.
However,
» Read more about: Anndy Lian: The Complex Challenges Faced by Cryptocurrency Exchanges »
Read More